Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population

References

• Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7:216–25.
   Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Reinier K, Teodorescu C, Evanado A, Kehr E, Al Samara M, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51:213–28.
   PubMed Web of Science ®Google Scholar
• Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999; 99:1978–83.
   PubMed Web of Science ®Google Scholar
• Friedlander Y, Siscovick DS, Arbogast P, Psaty BM, Weinmann S, Lemaitre RN, et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis. 2002;162:211–6.
   PubMed Web of Science ®Google Scholar
• Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112:207–13.
   PubMed Web of Science ®Google Scholar
• Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29:1670–80.
   Web of Science ®Google Scholar
• Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J. 1975;89:378–90.
   PubMed Web of Science ®Google Scholar
• Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129–33.
   PubMed Web of Science ®Google Scholar
• Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–9.
   Google Scholar
• Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569–80.
   PubMed Web of Science ®Google Scholar
• Roden DM. Clinical practice. Long-QT syndrome. N Engl J Med. 2008;358:169–76.
   PubMed Web of Science ®Google Scholar
• Basso C, Bauce B, Corrado D, Thiene G. Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2011;9:223–33.
   PubMed Web of Science ®Google Scholar
• Swan H, Piippo K, Viitasalo M, Heikkilä P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999;34:2035–42.
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200.
   PubMed Web of Science ®Google Scholar
• Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485–90.
   PubMed Web of Science ®Google Scholar
• Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378–84.
   PubMed Web of Science ®Google Scholar
• Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet. 1999;8:1913–23.
   PubMed Web of Science ®Google Scholar
• Fodstad H, Swan H, Laitinen P, Piippo K, Paavonen K, Viitasalo M, et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med. 2004;36(Suppl 1):53–63.
   Google Scholar
• Lahtinen AM, Lehtonen A, Kaartinen M, Toivonen L, Swan H, Widén E, et al. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol. 2008;126:92–100.
   Google Scholar
• Lahtinen AM, Lehtonen E, Marjamaa A, Kaartinen M, Heliö T, Porthan K, et al. Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2011;8:1214–21.
   PubMed Web of Science ®Google Scholar
• Marjamaa A, Laitinen-Forsblom P, Wronska A, Toivonen L, Kontula K, Swan H. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro. Int J Cardiol. 2011;147:246–52.
   Google Scholar
• Marjamaa A, Salomaa V, Newton-Cheh C, Porthan K, Reunanen A, Karanko H, et al. High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med. 2009;41:234–40.
   PubMed Web of Science ®Google Scholar
• Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47: 362–7.
   PubMed Web of Science ®Google Scholar
• Noseworthy PA, Havulinna AS, Porthan K, Lahtinen AM, Jula A, Karhunen PJ, et al. Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study. Circ Cardiovasc Genet. 2011;4:305–11.
   Google Scholar
• Nieminen T, Lehtimäki T, Viik J, Lehtinen R, Nikus K, Kööbi T, et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J. 2007;28:2332–7.
   PubMedGoogle Scholar
• Slawnych MP, Nieminen T, Kähönen M, Kavanagh KM, Lehtimäki T, Ramadan D, et al. Post-exercise assessment of cardiac repolarization alternans in patients with coronary artery disease using the modified moving average method. J Am Coll Cardiol. 2009;53:1130–7.
   PubMedGoogle Scholar
• Tobin MD, Kähönen M, Braund P, Nieminen T, Hajat C, Tomaszewski M, et al. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int J Epidemiol. 2008;37:1132–41.
   PubMedGoogle Scholar
• Marjamaa A, Newton-Cheh C, Porthan K, Reunanen A, Lahermo P, Väänänen H, et al. Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med. 2009;265:448–58.
   PubMedGoogle Scholar
• Raitakari OT, Blom-Nyholm J, Koskinen TA, Kähönen M, Viikari JS, Lehtimäki T. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study. Ann Med. 2009;41:144–51.
   Google Scholar
• Koskela J, Kähönen M, Fan M, Nieminen T, Lehtinen R, Viik J, et al. Effect of common KCNE1 and SCN5A ion channel gene variants on T-wave alternans, a marker of cardiac repolarization, during clinical exercise stress test: the Finnish Cardiovascular Study. Transl Res. 2008;152:49–58.
   PubMedGoogle Scholar
• Koskela J, Kähönen M, Nieminen T, Lehtinen R, Viik J, Nikus K, et al. Allelic variant of NOS1AP effects on cardiac alternans of repolarization during exercise testing. Scand J Clin Lab Invest. 2012;72:100–7.
   PubMed Web of Science ®Google Scholar
• Lahtinen AM, Noseworthy PA, Havulinna AS, Jula A, Karhunen PJ, Kettunen J, et al. Common genetic variants associated with sudden cardiac death: the FinSCDgen study. PLoS One. 2012;7:e41675.
   Google Scholar
• Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2010;39:504–18.
   PubMed Web of Science ®Google Scholar
• Heistaro S. Methodology report, Health 2000 Survey. Helsinki: Publications of the National Public Health Institute, KTL B 26; 2008.
   Google Scholar
• Kattainen A, Salomaa V, Härkänen T, Jula A, Kaaja R, Kesäniemi YA, et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J. 2006;27:296–301.
   PubMed Web of Science ®Google Scholar
• Tyynelä P, Goebeler S, Ilveskoski E, Mikkelsson J, Perola M, Löytönen M, et al. Birthplace predicts risk for prehospital sudden cardiac death in middle-aged men who migrated to metropolitan area: The Helsinki Sudden Death Study. Ann Med. 2009;41:57–65.
   Web of Science ®Google Scholar
• Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, et al. Apolipoprotein E-dependent accumulation of Alzheimer disease- related lesions begins in middle age. Ann Neurol. 2009;65:650–7.
   PubMed Web of Science ®Google Scholar
• Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78:1479–87.
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761–7.
   PubMed Web of Science ®Google Scholar
• Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 1994;3:959–62.
   PubMed Web of Science ®Google Scholar
• Peters S, Tr mmel M, Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol. 2004;97:499–501.
   PubMed Web of Science ®Google Scholar
• van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2006;113:1650–8.
   PubMed Web of Science ®Google Scholar
• Watkins DA, Hendricks N, Shaboodien G, Mbele M, Parker M, Vezi BZ, et al. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm. 2009;6:S10–S17.
   Web of Science ®Google Scholar
• van der Zwaag PA, Cox MG, van der Werf C, Wiesfeld AC, Jongbloed JD, Dooijes D, et al. Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J. 2010;18:583–91.
   Google Scholar
• Piippo K, Laitinen P, Swan H, Toivonen L, Viitasalo M, Pasternack M, et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol. 2000;35:1919–25.
   PubMed Web of Science ®Google Scholar
• Piippo K, Swan H, Pasternack M, Chapman H, Paavonen K, Viitasalo M, et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol. 2001;37:562–8.
   PubMed Web of Science ®Google Scholar
• Fodstad H, Bendahhou S, Rougier JS, Laitinen-Forsblom PJ, Barhanin J, Abriel H, et al. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann Med. 2006;38:294–304.
   PubMed Web of Science ®Google Scholar
• Hall C, Li S, Li H, Creason V, Wahl JK 3rd. Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability. Cell Commun Adhes. 2009;16:15–27.
   PubMed Web of Science ®Google Scholar
• Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335–48.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol. 2004;43:1625–9.
   PubMed Web of Science ®Google Scholar
• Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007;49:240–6.
   PubMed Web of Science ®Google Scholar
• Albert CM, Nam EG, Rimm EB, Jin HW, Hajjar RJ, Hunter DJ, et al. Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation. 2008;117:16–23.
   PubMed Web of Science ®Google Scholar
• Adabag AS, Peterson G, Apple FS, Titus J, King R, Luepker RV. Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J. 2010;159:33–9.
   Google Scholar
• Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc. 2004;79:1380–4.
   PubMedGoogle Scholar
• Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2004;1:600–7.
   PubMed Web of Science ®Google Scholar